======= CSRNP1 =======
== Gene Information ==
* **Official Symbol**: CSRNP1
* **Official Name**: cysteine and serine rich nuclear protein 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=64651|64651]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q96S65|Q96S65]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CSRNP1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CSRNP1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/606458|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a protein that localizes to the nucleus and expression of this gene is induced in response to elevated levels of axin. The Wnt signalling pathway, which is negatively regulated by axin, is important in axis formation in early development and impaired regulation of this signalling pathway is often involved in tumors. A decreased level of expression of this gene in tumors compared to the level of expression in their corresponding normal tissues suggests that this gene product has a tumor suppressor function. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016].
* **UniProt Summary**: Binds to the consensus sequence 5'-AGAGTG-3' and has transcriptional activator activity (By similarity). May have a tumor-suppressor function. May play a role in apoptosis. {ECO:0000250, ECO:0000269|PubMed:11526492}.
No Pfam Domain information is available for this gene.
|face morphogenesis|
|platelet-derived growth factor receptor signaling pathway|
|head morphogenesis|
|body morphogenesis|
|face development|
|post-embryonic development|
|roof of mouth development|
|skeletal system morphogenesis|
|sequence-specific DNA binding|
|DNA-binding transcription activator activity, RNA polymerase II-specific|
|skeletal system development|
|transmembrane receptor protein tyrosine kinase signaling pathway|
|DNA-binding transcription factor activity|
|enzyme linked receptor protein signaling pathway|
|molecular function|
|head development|
|apoptotic process|
|animal organ morphogenesis|
|programmed cell death|
|cell death|
|positive regulation of transcription by RNA polymerase II|
|positive regulation of transcription, DNA-templated|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|positive regulation of RNA metabolic process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|1.91|
^Gene^Correlation^
|[[:human genes:m:med13|MED13]]|0.42|
|[[:human genes:m:med13l|MED13L]]|0.415|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 2306
* **Expression level (log2 read counts)**: 3.09
{{:chemogenomics:nalm6 dist.png?nolink |}}